BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22579669)

  • 1. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
    Bini F; Frati A; Garcia-Gil M; Battistini C; Granado M; Martinesi M; Mainardi M; Vannini E; Luzzati F; Caleo M; Peretto P; Gomez-Muñoz A; Meacci E
    Neuropharmacology; 2012 Sep; 63(4):524-37. PubMed ID: 22579669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide kinase: the first decade.
    Bornancin F
    Cell Signal; 2011 Jun; 23(6):999-1008. PubMed ID: 21111813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D
    Pierucci F; Garcia-Gil M; Frati A; Bini F; Martinesi M; Vannini E; Mainardi M; Luzzati F; Peretto P; Caleo M; Meacci E
    Neuropharmacology; 2017 Apr; 116():328-342. PubMed ID: 28077289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATRA inhibits ceramide kinase transcription in a human neuroblastoma cell line, SH-SY5Y cells: the role of COUP-TFI.
    Murakami M; Ito H; Hagiwara K; Yoshida K; Sobue S; Ichihara M; Takagi A; Kojima T; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Suzuki M; Banno Y; Nozawa Y; Murate T
    J Neurochem; 2010 Jan; 112(2):511-20. PubMed ID: 19903244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytosolic phospholipase A(2)α in cell rounding and cytotoxicity induced by ceramide-1-phosphate via ceramide kinase.
    Nakamura H; Tada E; Makiyama T; Yasufuku K; Murayama T
    Arch Biochem Biophys; 2011 Aug; 512(1):45-51. PubMed ID: 21621503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ceramide, ceramidase inhibition and expression of ceramide kinase on cytosolic phospholipase A2alpha; additional role of ceramide-1-phosphate in phosphorylation and Ca2+ signaling.
    Shimizu M; Tada E; Makiyama T; Yasufuku K; Moriyama Y; Fujino H; Nakamura H; Murayama T
    Cell Signal; 2009 Mar; 21(3):440-7. PubMed ID: 19101626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice.
    Graf C; Niwa S; Müller M; Kinzel B; Bornancin F
    Biochem Biophys Res Commun; 2008 Aug; 373(1):159-63. PubMed ID: 18555012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator.
    Maupas-Schwalm F; Augé N; Robinet C; Cambus JP; Parsons SJ; Salvayre R; Nègre-Salvayre A
    FASEB J; 2004 Sep; 18(12):1398-400. PubMed ID: 15231724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase.
    Kleuser B; Cuvillier O; Spiegel S
    Cancer Res; 1998 May; 58(9):1817-24. PubMed ID: 9581819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide 1-phosphate induces neointimal formation via cell proliferation and cell cycle progression upstream of ERK1/2 in vascular smooth muscle cells.
    Kim TJ; Kang YJ; Lim Y; Lee HW; Bae K; Lee YS; Yoo JM; Yoo HS; Yun YP
    Exp Cell Res; 2011 Aug; 317(14):2041-51. PubMed ID: 21624361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide kinase: a potential anti-inflammatory target?
    Saxena S; Banerjee M; Shirumalla RK; Ray A
    Curr Opin Investig Drugs; 2008 May; 9(5):455-62. PubMed ID: 18465654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin.
    Boath A; Graf C; Lidome E; Ullrich T; Nussbaumer P; Bornancin F
    J Biol Chem; 2008 Mar; 283(13):8517-26. PubMed ID: 18086664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes.
    Tsuji K; Mitsutake S; Yokose U; Sugiura M; Kohama T; Igarashi Y
    FEBS J; 2008 Aug; 275(15):3815-26. PubMed ID: 18565104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
    Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
    Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
    Hait NC; Maiti A
    Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
    Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
    Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.